Cellectis Bioresearch, Axxam Collaborate on Cell-based Assays | GenomeWeb

NEW YORK (GenomeWeb News) – Cellectis Bioresearch today announced a collaboration with Axxam to offer integrated discovery services based on genomic engineering technologies.

According to Cellectis, a genome engineering firm, the collaboration will offer a one-stop shop approach to generating cell-based assays to the life science industry. Cellectis will use its genome engineering methods to modify genes of interest, and then Axxam will apply its expertise and technologies for cell line generation to develop functional cellular assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.